Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

1.8K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.8K
Inhaled Medications01:23

Inhaled Medications

880
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
880
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.7K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.7K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perceptions, attitudes, and real-world use of FENO in allergy and asthma practice: Results of a national survey from türkiye.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Fractional exhaled nitric oxide and practical points in asthma diagnosis and management.

Tuberkuloz ve toraks·2026
Same author

Allergen Immunotherapy for the Treatment of Eosinophilic Esophagitis. An EAACI Task Force Systematic Review.

Clinical and translational allergy·2026
Same author

Redefining asthma through new immune response pattern: A clinically driven perspective.

Respiratory medicine·2026
Same author

PECU: A multicenter study on pediatric patients with cold-induced urticaria.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Biphasic, Refractory, and Persistent Anaphylaxis in Children.

Clinical and translational allergy·2026

Related Experiment Video

Updated: Feb 22, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K

Physicians' preference for controller medication in mild persistent asthma.

Arzu Bakirtas1, Ali Kutlu2, Ayse Baccioglu3

  • 1Department of Pediatric Allergy and Asthma, Gazi University School of Medicine, Ankara, Turkey.

Respiratory Medicine
|September 27, 2017
PubMed
Summary

Turkish physicians overwhelmingly prefer inhaled corticosteroids (ICS) for mild persistent asthma over leukotriene receptor antagonists (LTRAs). Physician training and perceived medication effectiveness significantly influence this choice.

Keywords:
AsthmaMildPersistentPhysicianPreferenceTreatment

More Related Videos

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
02:34

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Published on: May 10, 2024

2.0K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

5.5K

Related Experiment Videos

Last Updated: Feb 22, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K
Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
02:34

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Published on: May 10, 2024

2.0K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

5.5K

Area of Science:

  • Pulmonology and Respiratory Medicine
  • Clinical Pharmacy and Pharmacology
  • Allergy and Immunology

Background:

  • Asthma guidelines recommend inhaled corticosteroids (ICS) or leukotriene receptor antagonists (LTRAs) for mild persistent asthma.
  • Physician preferences for controller medications in mild persistent asthma are not well understood.
  • This study investigates physician choices and the factors influencing them.

Purpose of the Study:

  • To determine the preferred first-line controller medication for mild persistent asthma among Turkish physicians.
  • To identify physician- and patient-related factors associated with the selection of ICS versus LTRAs.

Main Methods:

  • A 16-question self-administered questionnaire was distributed to physicians.
  • The survey targeted members of the Turkish National Society of Allergy and Clinical Immunology and congress attendees.
  • Data from 336 complete questionnaires were analyzed using logistic regression.

Main Results:

  • Low-dose ICS was the preferred first-choice controller medication for mild persistent asthma by 84.5% of physicians.
  • Physician preference for ICS was associated with adherence to asthma guidelines and perceived efficacy.
  • Preference for LTRAs was linked to being a pediatrician and perceived better patient compliance.

Conclusions:

  • The majority of surveyed Turkish physicians prefer ICS over LTRAs for managing mild persistent asthma.
  • Physician training background, adherence to guidelines, perceived efficacy, and patient compliance influence medication choice.
  • These findings highlight key factors shaping therapeutic decisions in mild persistent asthma management.